NCT03997253 Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management
| NCT ID | NCT03997253 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Limoges |
| Condition | Organ Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 430 participants |
| Start Date | 2020-12-21 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 430 participants in total. It began in 2020-12-21 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Increased indications for transplantation continue to worsen the shortage of organs and need the extension of graft sampling criteria and the search for new potential sources of organs. Despite undeniable success in the short term, due to major advances in surgery, medicine and research, transplant recipients continue to face the risk of chronic rejection and long-term complications. The University Hospital Federation "FHU SUPORT" was created to optimize the chances of success of the organ transplant and improve the quality of life of the transplanted patient. FHU SUPORT 's ambition is based on a translational strategy that presents two priority areas: Axis 1: Optimization, evaluation, conditioning of the donor, graft, recipient Axis 2: Personalized follow-up of the transplanted patient in the short and long term Identifying factors for long-term graft and patient survival through translational research from a common cohort and biological collection will predict transplant rejection, prolong graft function, or improve the patient's care.
Eligibility Criteria
Inclusion Criteria: * Male or female over 18 (no age limit) * affiliated to a social security organization * Recipient (s) of a kidney, liver or heart transplant * followed by at least one of the FHU SUPORT centers (Tours, Poitiers, Limoges, Rennes) * having given informed consent to participate in the cohort. Exclusion Criteria: * Patient unable to understand the information given by the investigator * People under the protection of justice
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03997253 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Organ Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03997253 currently recruiting?
Yes, NCT03997253 is actively recruiting participants. Contact the research team at sophie.alain@unilim.fr for enrollment information.
Where is the NCT03997253 trial being conducted?
This trial is being conducted at Limoges, France, Poitiers, France, Rennes, France, Tours, France.
Who is sponsoring the NCT03997253 clinical trial?
NCT03997253 is sponsored by University Hospital, Limoges. The trial plans to enroll 430 participants.